Exacerbation of acetaminophen hepatotoxicity by thalidomide and protection by nicotinic acid amide
- 1 October 1995
- journal article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 26 (6) , 1243-1247
- https://doi.org/10.1016/0306-3623(95)00019-w
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Thalidomide: can it continue to be used?The Lancet, 1994
- Chronic Bullous Disease of Childhood and Ulcerative ColitisPediatric Dermatology, 1993
- Copper-dependent antioxidase defenses in inflammatory and autoimmune rheumatic diseasesInflammation, 1993
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- Recent Advances in Cytokine Therapy in LeprosyThe Journal of Infectious Diseases, 1993
- 3-aminobenzamide protects the mouse thymocytes in vitro from dexamethasone-mediated apoptotic cell death and cytolysis without changing DNA strand breakageThe Journal of Steroid Biochemistry and Molecular Biology, 1993
- Nuclear Factor Kb: An Oxidative Stress-Responsive Transcription Factor of Eukaryotic Cells (A Review)Free Radical Research Communications, 1992
- Evidence for the involvement of a reperfusion injury in galactosamine/endotoxin-induced hepatitis in miceBiochemical Pharmacology, 1987
- Chromatographic Resolution of Chiral Drugs on Polyamides and Cellulose TriacetateJournal of Liquid Chromatography, 1986
- Prooxidant States and Tumor PromotionScience, 1985